LRRK2-IN-21

Overview

LRRK2-IN-21 is a selective, blood-brain barrier-permeable LRRK2 kinase inhibitor with an IC 50 of 0.35 nM. LRRK2-IN-21 inhibits TTK kinase with an IC 50 of 70 nM. LRRK2-IN-21 is applicable to the research of Parkinson's disease.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > LRRK2 | Products > Signaling Pathways > Mps1

Product Information

• Catalog No.: HY-182928
• CAS No.: 3018825-60-7
• Molecular Formula: C17H19F3N6O2
• Molecular Weight: 396.37
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source